A Single-dose Escalation Safety and PK Study for PLC in Healthy Chinese

NCT02786069 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

16

Enrollment

INDUSTRY

Sponsor class

Conditions

Peripheral Arterial Disease

Interventions

DRUG: Propionyl L-carnitine Hydrochloride

Sponsor

Lee's Pharmaceutical Limited